In this episode, learn about the importance of identifying adults at risk for reduced hepatitis B virus (HBV) seroprotection and applying current HBV vaccine recommendations in special populations. Listen as Robert G. Gish, MD, discusses key information on the identification and evaluation of patients who have chronic health conditions and therefore may be at risk for nonresponse to available vaccines.Presenter: Robert G. Gish, MDProfessor of MedicineLoma Linda UniversityLoma Linda, CaliforniaAdjunct Professor of MedicineNevada School of MedicineLas Vega, NevadaClinical ProfessorUniversity of Nevada Reno School of MedicineReno, NevadaClinical ProfessorUniversity of California Skaggs School of Pharmacy and Pharmaceutical SciencesSan Diego, CaliforniaMedical DirectorHepatitis B FoundationWashington, DCReview the downloadable slidesets at:https://bit.ly/3KPiJZzLink to full program:https://bit.ly/3OZ50Ta Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related